Now that the Supreme Court has invalidated Bilski and Warsaw's business methods patent, many are left wondering how the ruling may affect the personalized medicine industry. The article, Patent Strategy for Personalized Medicine in Light of Bilski, discusses the implications of the Bilski decision on such inventions.
« The Court Decides! | Main | The Buzz about Bilski »
07/16/2010
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a011570f4033a970c0133f2546a15970b
Listed below are links to weblogs that reference Patent Strategy for Personalized Medicine after Bilski:
Comments
Recent Posts
- Breyer's Reinvention of the 'Inventive Concept'
- Is There Life After Bilski? Yes, but It’s Not as We Know It: A Response to Michael Risch
- Patent Claims and the Use of Abstractions
- Patent Eligibility: The Historical Cases
- The Normative Stance of Patent Eligibility
- The Normativist View of Section 101 and the Hidden Lessons in the Supreme Court's Cases
- CLS v. Alice: The Federal Circuit at a Jurisprudential Deadlock
- The Confusion between Abstractions and Abstract Intellectual Ideas
- Bilski Blog is Back!
- Canadian Court's Decision References Bilski Case
Subscribe via RSS